collection
https://read.qxmd.com/read/33439554/the-utility-of-18f-fdg-pet-ct-in-patients-with-clinical-suspicion-of-polymyalgia-rheumatica-and-giant-cell-arteritis-a-prospective-observational-and-cross-sectional-study
#1
JOURNAL ARTICLE
Amir Emamifar, Torkell Ellingsen, Søren Hess, Oke Gerke, Rasmus Hviid Larsen, Ziba Ahangarani Farahani, Per Syrak Hansen, Inger Marie Jensen Hansen, Henrik Petersen, Niels Marcussen, Michael Dahlstrøm, Pia Toftegaard, Peter Thye-Rønn
OBJECTIVE: To define the proportions of agreement between fluorine-18-fluorodeoxyglucose (18F-FDG) positron emission tomography/computed tomography (PET/CT), clinical diagnosis, and temporal artery biopsy (TAB) in patients with polymyalgia rheumatica (PMR) and giant cell arteritis (GCA). Furthermore, the association of 18F-FDG PET/CT uptake patterns and clinical presentation of newly diagnosed PMR and GCA was investigated. METHODS: Eighty patients newly suspected of having PMR, GCA, or concomitant PMR and GCA were included and followed for 40 weeks...
August 2020: ACR open rheumatology
https://read.qxmd.com/read/26929219/efficacy-of-first-line-tocilizumab-therapy-in-early-polymyalgia-rheumatica-a-prospective-longitudinal-study
#2
MULTICENTER STUDY
Valérie Devauchelle-Pensec, Jean Marie Berthelot, Divi Cornec, Yves Renaudineau, Thierry Marhadour, Sandrine Jousse-Joulin, Solène Querellou, Florent Garrigues, Michel De Bandt, Maelenn Gouillou, Alain Saraux
BACKGROUND: Glucocorticoids are the cornerstone treatment of polymyalgia rheumatica (PMR) but induce adverse events. OBJECTIVES: To evaluate the efficacy and safety of first-line tocilizumab in PMR. METHODS: In a prospective open-label study (ClinicalTrials.gov: NCT01713842), 20 glucocorticoid-free patients fulfilling Chuang's PMR criteria, with symptom onset within the last 12 months and a PMR activity score (PMR-AS) >10, each received three tocilizumab infusions at 4-week intervals, without glucocorticoids, followed by oral prednisone from weeks 12 to 24 (0...
August 2016: Annals of the Rheumatic Diseases
https://read.qxmd.com/read/26683194/2015-eular-acr-recommendations-for-polymyalgia-rheumatica-the-message-and-next-steps
#3
EDITORIAL
Lauren Steel, Marwan Bukhari, Bhaskar Dasgupta
No abstract text is available yet for this article.
June 2016: Rheumatology
https://read.qxmd.com/read/26352874/2015-recommendations-for-the-management-of-polymyalgia-rheumatica-a-european-league-against-rheumatism-american-college-of-rheumatology-collaborative-initiative
#4
JOURNAL ARTICLE
Christian Dejaco, Yogesh P Singh, Pablo Perel, Andrew Hutchings, Dario Camellino, Sarah Mackie, Andy Abril, Artur Bachta, Peter Balint, Kevin Barraclough, Lina Bianconi, Frank Buttgereit, Steven Carsons, Daniel Ching, Maria Cid, Marco Cimmino, Andreas Diamantopoulos, William Docken, Christina Duftner, Billy Fashanu, Kate Gilbert, Pamela Hildreth, Jane Hollywood, David Jayne, Manuella Lima, Ajesh Maharaj, Christian Mallen, Victor Martinez-Taboada, Mehrdad Maz, Steven Merry, Jean Miller, Shunsuke Mori, Lorna Neill, Elisabeth Nordborg, Jennifer Nott, Hannah Padbury, Colin Pease, Carlo Salvarani, Michael Schirmer, Wolfgang Schmidt, Robert Spiera, David Tronnier, Alexandre Wagner, Madeline Whitlock, Eric L Matteson, Bhaskar Dasgupta
Therapy for polymyalgia rheumatica (PMR) varies widely in clinical practice as international recommendations for PMR treatment are not currently available. In this paper, we report the 2015 European League Against Rheumatism (EULAR)/American College of Rheumatology (ACR) recommendations for the management of PMR. We used the Grading of Recommendations, Assessment, Development and Evaluation (GRADE) methodology as a framework for the project. Accordingly, the direction and strength of the recommendations are based on the quality of evidence, the balance between desirable and undesirable effects, patients' and clinicians' values and preferences, and resource use...
October 2015: Arthritis & Rheumatology
https://read.qxmd.com/read/26376658/whole-body-mri-of-patients-with-polymyalgia-rheumatica-identifies-a-distinct-subset-with-complete-patient-reported-response-to-glucocorticoids
#5
JOURNAL ARTICLE
Sarah Louise Mackie, Colin Thomas Pease, Eiji Fukuba, Emma Harris, Paul Emery, Richard Hodgson, Jane Freeston, Dennis McGonagle
OBJECTIVES: To determine whether whole-body MRI defines clinically relevant subgroups within polymyalgia rheumatica (PMR) including glucocorticoid responsiveness. METHODS: 22 patients with PMR and 16 with rheumatoid arthritis (RA), untreated and diagnosed by consultant rheumatologists, underwent whole-body, multiple-joint MRI, scored by two experts. Patients with PMR reported whether they felt 'back to normal' on glucocorticoid therapy and were followed for a median of 2 years...
December 2015: Annals of the Rheumatic Diseases
https://read.qxmd.com/read/26359489/current-evidence-for-therapeutic-interventions-and-prognostic-factors-in-polymyalgia-rheumatica-a-systematic-literature-review-informing-the-2015-european-league-against-rheumatism-american-college-of-rheumatology-recommendations-for-the-management-of-polymyalgia
#6
REVIEW
Christian Dejaco, Yogesh P Singh, Pablo Perel, Andrew Hutchings, Dario Camellino, Sarah Mackie, Eric L Matteson, Bhaskar Dasgupta
To summarise evidence on therapeutic interventions and prognostic factors in polymyalgia rheumatica (PMR). A systematic literature review was conducted using Ovid Medline, Embase, PubMed, CINAHL, Web of Science and the Cochrane Library (1970 through April 2014). Quality of evidence (QoE) of identified studies was appraised by Grading of Recommendations Assessment, Development and Evaluation (GRADE) (interventions) and the Quality In Prognosis Studies (QUIPS) methodologies (prognostic factors). Out of 10 931 titles identified, 52 articles were finally selected...
October 2015: Annals of the Rheumatic Diseases
https://read.qxmd.com/read/26359488/2015-recommendations-for-the-management-of-polymyalgia-rheumatica-a-european-league-against-rheumatism-american-college-of-rheumatology-collaborative-initiative
#7
JOURNAL ARTICLE
Christian Dejaco, Yogesh P Singh, Pablo Perel, Andrew Hutchings, Dario Camellino, Sarah Mackie, Andy Abril, Artur Bachta, Peter Balint, Kevin Barraclough, Lina Bianconi, Frank Buttgereit, Steven Carsons, Daniel Ching, Maria Cid, Marco Cimmino, Andreas Diamantopoulos, William Docken, Christina Duftner, Billy Fashanu, Kate Gilbert, Pamela Hildreth, Jane Hollywood, David Jayne, Manuella Lima, Ajesh Maharaj, Christian Mallen, Victor Martinez-Taboada, Mehrdad Maz, Steven Merry, Jean Miller, Shunsuke Mori, Lorna Neill, Elisabeth Nordborg, Jennifer Nott, Hannah Padbury, Colin Pease, Carlo Salvarani, Michael Schirmer, Wolfgang Schmidt, Robert Spiera, David Tronnier, Alexandre Wagner, Madeline Whitlock, Eric L Matteson, Bhaskar Dasgupta
Therapy for polymyalgia rheumatica (PMR) varies widely in clinical practice as international recommendations for PMR treatment are not currently available. In this paper, we report the 2015 European League Against Rheumatism (EULAR)/American College of Rheumatology (ACR) recommendations for the management of PMR. We used the Grading of Recommendations, Assessment, Development and Evaluation (GRADE) methodology as a framework for the project. Accordingly, the direction and strength of the recommendations are based on the quality of evidence, the balance between desirable and undesirable effects, patients' and clinicians' values and preferences, and resource use...
October 2015: Annals of the Rheumatic Diseases
1
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.